These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
511 related articles for article (PubMed ID: 1674898)
1. Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer. McCann AH; Dervan PA; O'Regan M; Codd MB; Gullick WJ; Tobin BM; Carney DN Cancer Res; 1991 Jun; 51(12):3296-303. PubMed ID: 1674898 [TBL] [Abstract][Full Text] [Related]
2. Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer. Paterson MC; Dietrich KD; Danyluk J; Paterson AH; Lees AW; Jamil N; Hanson J; Jenkins H; Krause BE; McBlain WA Cancer Res; 1991 Jan; 51(2):556-67. PubMed ID: 1670762 [TBL] [Abstract][Full Text] [Related]
3. Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer. Wright C; Angus B; Nicholson S; Sainsbury JR; Cairns J; Gullick WJ; Kelly P; Harris AL; Horne CH Cancer Res; 1989 Apr; 49(8):2087-90. PubMed ID: 2564806 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of proliferation associated nucleolar antigen P120 in human breast carcinoma. Freeman JW; McGrath P; Bondada V; Selliah N; Ownby H; Maloney T; Busch RK; Busch H Cancer Res; 1991 Apr; 51(8):1973-8. PubMed ID: 1672621 [TBL] [Abstract][Full Text] [Related]
5. Analysis of c-erbB-2 expression in breast carcinomas with clinical follow-up. Thor AD; Schwartz LH; Koerner FC; Edgerton SM; Skates SJ; Yin S; McKenzie SJ; Panicali DL; Marks PJ; Fingert HJ Cancer Res; 1989 Dec; 49(24 Pt 1):7147-52. PubMed ID: 2573426 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness. Sugano S; Mukai K; Tsuda H; Hirohashi S; Furuya S; Shimosato Y; Ebihara S; Takeyama I Laryngoscope; 1992 Aug; 102(8):923-7. PubMed ID: 1353853 [TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of immunohistochemical c-erbB-2 proto-oncogene expression and nuclear DNA content in human breast cancer. Schimmelpenning H; Eriksson ET; Falkmer UG; Rutqvist LE; Johansson H; Fallenius A; Auer GU Eur J Surg Oncol; 1992 Dec; 18(6):530-7. PubMed ID: 1362164 [TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer. Rudland PS; Platt-Higgins A; El-Tanani M; De Silva Rudland S; Barraclough R; Winstanley JH; Howitt R; West CR Cancer Res; 2002 Jun; 62(12):3417-27. PubMed ID: 12067984 [TBL] [Abstract][Full Text] [Related]
9. c-erbB-2 oncogene related to p53 expression, cell proliferation and prognosis in breast cancer. Lipponen HJ; Aaltomaa S; Syrjänen S; Syrjänen K Anticancer Res; 1993; 13(4):1147-52. PubMed ID: 8102517 [TBL] [Abstract][Full Text] [Related]
10. Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer. Nakamura Y; Yasuoka H; Tsujimoto M; Yang Q; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K Clin Cancer Res; 2003 Nov; 9(14):5313-7. PubMed ID: 14614015 [TBL] [Abstract][Full Text] [Related]
11. Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer. van de Vijver MJ; Peterse JL; Mooi WJ; Wisman P; Lomans J; Dalesio O; Nusse R N Engl J Med; 1988 Nov; 319(19):1239-45. PubMed ID: 2903446 [TBL] [Abstract][Full Text] [Related]
12. [Prognostic significance of expression of c-ERBB-2 oncoprotein in breast cancer patients]. Osaki A; Toi M; Yamada H; Kawami H; Kuroi K; Toge T Gan To Kagaku Ryoho; 1991 Jun; 18(7):1181-5. PubMed ID: 1675844 [TBL] [Abstract][Full Text] [Related]
13. Tissue microarray-based studies of patients with lymph node negative breast carcinoma show that met expression is associated with worse outcome but is not correlated with epidermal growth factor family receptors. Tolgay Ocal I; Dolled-Filhart M; D'Aquila TG; Camp RL; Rimm DL Cancer; 2003 Apr; 97(8):1841-8. PubMed ID: 12673709 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy. Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582 [TBL] [Abstract][Full Text] [Related]
15. Analysis of chromosomal aberrations in breast cancer by comparative genomic hybridization (CGH). Correlation with histoprognostic variables and c-erbB-2 immunoexpression. Malamou-Mitsi VD; Syrrou M; Georgiou I; Pagoulatos G; Agnantis NJ J Exp Clin Cancer Res; 1999 Sep; 18(3):357-61. PubMed ID: 10606182 [TBL] [Abstract][Full Text] [Related]
16. [Value of cancer-related oncoprotein expression as prognostic factors in breast-cancer with one to three axillary lymph nodes positive]. Zhang G; Tsuda H; Adachi I; Fukutomi T; Yamamoto H; Hirohashi S Gan To Kagaku Ryoho; 1996 Mar; 23 Suppl 1():66-74. PubMed ID: 8702314 [TBL] [Abstract][Full Text] [Related]
17. Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease. Press MF; Pike MC; Chazin VR; Hung G; Udove JA; Markowicz M; Danyluk J; Godolphin W; Sliwkowski M; Akita R Cancer Res; 1993 Oct; 53(20):4960-70. PubMed ID: 8104689 [TBL] [Abstract][Full Text] [Related]
18. Relationship between c-erbB-2 oncoprotein, epidermal growth factor receptor, and estrogen receptor expression in patients with ductal breast carcinoma. Association with tumor phenotypes. Harłoziñska A; Bar JK; Wenderski R; Bebenek M In Vivo; 1996; 10(2):217-22. PubMed ID: 8744803 [TBL] [Abstract][Full Text] [Related]
19. Correlation of clinical, pathological status, hormone receptor and C-erbB-2 oncoprotein in breast cancer patients. Aryandono T; Harijadi ; Ghozali A Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():600-6. PubMed ID: 10895217 [TBL] [Abstract][Full Text] [Related]
20. Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications. Rudolph P; Olsson H; Bonatz G; Ratjen V; Bolte H; Baldetorp B; Fernö M; Parwaresch R; Alm P J Pathol; 1999 Jan; 187(2):207-16. PubMed ID: 10365096 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]